8-K
filed May 15, 2025, 7:59 PM ET
ticker MNKD
CIK 0000899460
leadership
confidence high
sentiment neutral
materiality 0.50
MannKind Chief Medical Officer Burkhard Blank to depart; separation terms include $386K bonus
MANNKIND CORP
- Burkhard Blank stepped down as CMO and EVP R&D effective May 9, 2025, becoming non-executive employee.
- Last day of employment is August 1, 2025; base salary continued for 13 weeks through Oct 31, 2025.
- One-time special bonus of $386,000 payable in January 2026; COBRA premiums reimbursed until Oct 31.
- Equity awards continue to vest while Blank remains employed.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-25-120797
- form_type
- 8-K
- ticker
- MNKD
- cik
- 0000899460
- company_name
- MANNKIND CORP
- filed_at
- 2025-05-15T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:51.739272+00:00
- generated_at
- 2026-05-21T07:10:10.333833+00:00
- sec_items
- ["5.02"]
- event_type
- leadership
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-25-120797
- json_url
- https://secwatch.observer/filing/0001193125-25-120797.json
- markdown_url
- https://secwatch.observer/filing/0001193125-25-120797.md
- text_url
- https://secwatch.observer/filing/0001193125-25-120797.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/899460/000119312525120797/0001193125-25-120797-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/899460/000119312525120797/d915656d8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
Cornerstone Building Brands, Inc.
Cornerstone Building Brands names Richard Dirkson as Corporate Controller; CAO departs
Cornerstone Building Brands, Inc.
June 2, 2026, 10:32 AM ET
leadership
Items 5.02, 5.07
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 9, 2025, MannKind Corporation (the “Company”) and Burkhard Blank, Chief Medical Officer and Executive Vice President, Research & Development, mutually agreed that Mr. Blank would step down from his role as an executive officer of the Company.
Comparable filing
On May 27, 2026, the Company appointed Richard Dirkson as Senior Vice President, Corporate Controller (principal accounting officer) of the Company, effective May 28, 2026.
Filing page
SEC filing
ALH
COO International Jan Vleugels to retire Sept 30; Bob Calver named successor; new VP IR
Alliance Laundry Holdings Inc.
June 2, 2026, 9:16 AM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 9, 2025, MannKind Corporation (the “Company”) and Burkhard Blank, Chief Medical Officer and Executive Vice President, Research & Development, mutually agreed that Mr. Blank would step down from his role as an executive officer of the Company.
Comparable filing
Mr. Jan Vleugals, Chief Operating Officer International of Alliance Laundry Holdings Inc. (the “Company”), provided notice of his decision to retire effective as of September 30, 2026
Filing page
SEC filing
ONCY
Oncolytics appoints Steve Glover to board, promotes John McAdory to COO
ONCOLYTICS BIOTECH INC
June 2, 2026, 9:02 AM ET
leadership
Items 5.02, 8.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 9, 2025, MannKind Corporation (the “Company”) and Burkhard Blank, Chief Medical Officer and Executive Vice President, Research & Development, mutually agreed that Mr. Blank would step down from his role as an executive officer of the Company.
Comparable filing
appointed John McAdory as Chief Operating Officer of the Company
Filing page
SEC filing
ACHV
Achieve Life Sciences appoints Jeff Farrow and Dr. Reid Waldman to Board
ACHIEVE LIFE SCIENCES, INC.
June 2, 2026, 8:51 AM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 9, 2025, MannKind Corporation (the “Company”) and Burkhard Blank, Chief Medical Officer and Executive Vice President, Research & Development, mutually agreed that Mr. Blank would step down from his role as an executive officer of the Company.
Comparable filing
the Board of Directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”) appointed Jeff Farrow and Reid Waldman, M.D. (together, the “Incoming Directors”), as directors, effective as of such date.
Filing page
SEC filing
OSCR
Oscar Health Co-Founder Schlosser transitions from CTO to Advisor to CEO
Oscar Health, Inc.
June 2, 2026, 6:31 AM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 9, 2025, MannKind Corporation (the “Company”) and Burkhard Blank, Chief Medical Officer and Executive Vice President, Research & Development, mutually agreed that Mr. Blank would step down from his role as an executive officer of the Company.
Comparable filing
Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.
Filing page
SEC filing
PAGP
Plains GP Holdings announces CAO succession: Montgomery promoted, Herbold retiring
PLAINS GP HOLDINGS LP
June 2, 2026, 6:05 AM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 9, 2025, MannKind Corporation (the “Company”) and Burkhard Blank, Chief Medical Officer and Executive Vice President, Research & Development, mutually agreed that Mr. Blank would step down from his role as an executive officer of the Company.
Comparable filing
effective September 1, 2026, Russ Montgomery will be promoted to the position of Vice President, Accounting and Chief Accounting Officer of Plains All American GP LLC, the general partner of PAA, and PAA GP Holdings LLC, the general partner of PAGP.
Filing page
SEC filing
PAA
Plains All American announces CAO retirement and Montgomery promotion effective Sep 1, 2026
PLAINS ALL AMERICAN PIPELINE LP
June 2, 2026, 6:03 AM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 9, 2025, MannKind Corporation (the “Company”) and Burkhard Blank, Chief Medical Officer and Executive Vice President, Research & Development, mutually agreed that Mr. Blank would step down from his role as an executive officer of the Company.
Comparable filing
Chris Herbold, who previously served as Senior Vice President, Finance and Chief Accounting Officer of PAA and PAGP, is retiring from the company on August 31, 2026.
Filing page
SEC filing
AHCO
AdaptHealth amends 8-K to disclose COO Daniel McFadden's compensation: base salary raised to $550K, plus RSU grant
AdaptHealth Corp.
June 1, 2026, 9:02 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 9, 2025, MannKind Corporation (the “Company”) and Burkhard Blank, Chief Medical Officer and Executive Vice President, Research & Development, mutually agreed that Mr. Blank would step down from his role as an executive officer of the Company.
Comparable filing
the appointment of Daniel McFadden as Chief Operating Officer of the Company, effective as of May 4, 2026
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.